Selective regulation of IFN-γ and IL-4 co-producing unconventional T cells by purinergic signaling
Authors:
- Calvin XuCXCalvin Xu
- Andreas ObersAOAndreas Obers
- Minyi QinMQMinyi Qin
- Alice BrandliABAlice Brandli
- Joelyn WongJWJoelyn Wong
- Xin HuangXHXin Huang
- Allison ClatchACAllison Clatch
- Aly FayedAFAly Fayed
- Graham StarkeyGSGraham Starkey
- Rohit D’cOstaRDRohit D’cOsta
- Claire L. GordonCGClaire L. Gordon
- Jeffrey Y.W. MakJMJeffrey Y.W. Mak
Open Access
- 19 November 2024
- journal article
- research article
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 221 (12)
Abstract
Unconventional T cells, including mucosal-associated invariant T (MAIT), natural killer T (NKT), and gamma-delta T (γδT) cells, comprise distinct T-bet+, IFN-γ+ and RORγt+, IL-17+ subsets which play differential roles in health and disease. NKT1 cells are susceptible to ARTC2-mediated P2X7 receptor (P2RX7) activation, but the effects on other unconventional T-cell types are unknown. Here, we show that MAIT, γδT, and NKT cells express P2RX7 and are sensitive to P2RX7-mediated cell death. Mouse peripheral T-bet+ MAIT1, γδT1, and NKT1 cells, especially in liver, co-express ARTC2 and P2RX7. These markers could be further upregulated upon exposure to retinoic acid. Blocking ARTC2 or inhibiting P2RX7 protected MAIT1, γδT1, and NKT1 cells from cell death, enhanced their survival in vivo, and increased the number of IFN-γ–secreting cells without affecting IL-17 production. Importantly, this revealed the existence of IFN-γ and IL-4 co-producing unconventional T-cell populations normally lost upon isolation due to ARTC2/P2RX7-induced death. Administering extracellular NAD in vivo activated this pathway, depleting P2RX7-sensitive unconventional T cells. Our study reveals ARTC2/P2RX7 as a common regulatory axis modulating the unconventional T-cell compartment, affecting the viability of IFN-γ– and IL-4–producing T cells, offering important insights to facilitate future studies into how these cells can be regulated in health and disease.Keywords
All Related Versions
Funding Information
- National Health and Medical Research Council (1140126, 2008913, 2008913, 2009551, 1117766)
- Australian Research Council (DE220100830, CE200100012)
- Australian Postgraduate Award
- Sylvia and Charles Viertel Charitable Foundation
- National Institutes of Health (RO1 AI14807-01A1)
This publication has 81 references indexed in Scilit:
- P2X7 is expressed on human innate‐like T lymphocytes and mediates susceptibility to ATP‐induced cell deathEuropean Journal of Immunology, 2022
- Preparation of the Murine Anti-Human P2X7 Receptor Monoclonal Antibody (Clone L4)2022
- Mono-ADP-ribosylation sites of human CD73 inhibit its adenosine-generating enzymatic activityPurinergic Signalling, 2021
- Murine iNKT cells are depleted by liver damage via activation of P2RX7European Journal of Immunology, 2020
- P2X7-mediated ATP secretion is accompanied by depletion of cytosolic ATPPurinergic Signalling, 2019
- Proteomic Characterization of the Heart and Skeletal Muscle Reveals Widespread Arginine ADP-Ribosylation by the ARTC1 EctoenzymeCell Reports, 2018
- Evaluation of the expression and function of the P2X7 receptor and ART1 in human regulatory T-cell subsetsImmunobiology, 2016
- ADP-ribosylation of arginineAmino Acids, 2010
- Genetics of the P2X7 receptor and human diseasePurinergic Signalling, 2009
- P2X receptor-dependent ATP-induced shedding of CD27 in mouse lymphocytesImmunology Letters, 2006